Evaluation and Treatment of Febrile Ulceronecrotic Mucha-Habermann Disease With Ruxolitinib and Tocilizumab as Guided by Cytokine Profile.
Citation: JAMA Dermatology. 157(11):1381-1383, 2021 11 01.PMID: 34643656Institution: MedStar Washington Hospital CenterDepartment: Medical Dermatology ResidencyForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *Pityriasis Lichenoides | Antibodies, Monoclonal, Humanized | Cytokines | Herpes Simplex | Humans | Nitriles | Pityriasis Lichenoides/th [Therapy] | Pyrazoles | PyrimidinesYear: 2021ISSN:- 2168-6068
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 34643656 | Available | 34643656 |
English